May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Toronto Hospital Glaucoma Health and Sleep Survey (THGHSS): Depressive Symptomatology in Tertiary-Care Glaucoma Patients
Author Affiliations & Notes
  • J.G. Flanagan
    Department of Ophthalmology, Univ of Toronto, Toronto, ON, Canada
  • P.O. Lundmark
    School of Optometry, Buskerud University College, Buskerud, Norway
  • G.E. Trope
    School of Optometry, Buskerud University College, Buskerud, Norway
  • Footnotes
    Commercial Relationships  J.G. Flanagan, None; P.O. Lundmark, None; G.E. Trope, None.
  • Footnotes
    Support  CIHR MOP-14612
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4361. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.G. Flanagan, P.O. Lundmark, G.E. Trope; The Toronto Hospital Glaucoma Health and Sleep Survey (THGHSS): Depressive Symptomatology in Tertiary-Care Glaucoma Patients . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4361.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate depressive symptomatology among patients with glaucoma and to relate findings to disease stability. Methods: The Center for Epidemiological Studies Depression Scale (CES-D) questionnaire, along with questions related to general health and use of medications, were mailed to 1814 glaucoma patients registered in a tertiary referral center. Responders were included if i) their diagnosis was either primary open angle glaucoma (POAG), normal tension glaucoma (NTG), or primary angle-closure glaucoma (PACG) in at least one eye, ii) the disease duration was 3 years or more, and iii) clinical examinations were obtained annually. A subsample with reliable perimetric results was selected and classified as either stable or progressive, based on pointwise decline in the visual field. Groups were compared using bivariate and multivariate statistical analyses. Results: There were 884 responders (53% response rate). Disease stability was determined in a subsample of 269 patients of which 179 were classified as stable. Prevalence of depressive symptoms was 24% in stable disease and 11% in those with progressive disease. The adjusted odds ratio for depressive symptoms in stable disease was 3.7 (1.4 – 9.4, p= 0.007). There was no significant difference in depressive symptoms between POAG, NTG and PACG. Conclusions: Contrary to expectation, depressive symptoms were 3.7 times more common in stable than progressive disease.

Keywords: quality of life • clinical (human) or epidemiologic studies: ris 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×